Cancer Biomarkers - iCrowdNewswire
  • Spain
  • Brazil
  • Russia
  • France
  • Germany
  • China
  • Korea
  • Japan

RSS Newsfeeds

See all RSS Newsfeeds

Nov 10, 2018 4:40 PM ET

Cancer Biomarkers

iCrowdNewswire - Nov 10, 2018

Cancer Biomarkers

Cancer Biomarkers Market report brings together multiple data sources to provide a comprehensive overview of the leading manufacturers, countries, revenue, consumption, suppliers, production, sales, opportunities, market risk, market driving force.

Company Coverage of Cancer Biomarkers market includes Abbott Laboratories, Affymetrix Inc., (Thermo Fisher Scientific), Agilent Technologies, Hologic Inc., Roche Holding AG, 23andMe, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), Illumina Inc..

Read full Research Report at

Key Developments in the Cancer Biomarkers Market:

  • January 2018: Roche and GE entered into a partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment. This partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics, and sequencing portfolio.
  • January 2018: New biomarkers found for colorectal cancer (MYO5B).
  • November 2017: Researchers found a new biomarker for breast cancer (GIRK1).
  • October 2017: ABBOTT acquired ALERE.
  • September 2017: Roche announced its progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress.

    Cancer Biomarkers Market Dynamics

  • Drivers– Increased Incidences of Cancer Globally and Higher Acceptance for Treatment in Developing Regions– Paradigm Shift in Healthcare from Disease Diagnosis to Risk Assessment or Early Diagnosis– Increasing Usage in Drug Development
  • Restraints– High Cost of Diagnosis– Reimbursement Issues– Need for Immediate Processing
  • Opportunities
  • Key Challenges

    Geographical Coverage: US, Canada, Mexico, France, UK, Germany, Italy, Spain, China, Japan, India, Australia & New Zealand, South Korea, GCC, South Africa, Brazil, Argentina.

    Request for Sample of Report at

    Questions Answered in the Report:

    • How the Cancer Biomarkers market grows in last few years?
    • How the top players in the market perform in past and future with player’s profiles and sales data?
    • What are the types and applications?
    • How production & sales going on in Cancer Biomarkers market?
    • How the imports and exports going on in major countries?
    • What is revenue, market share, consumption, gross margin for Cancer Biomarkers?
    • What are upstream and downstream of market?
    • How the Cancer Biomarkers market is growing in 2018-2023?
    • What are the research findings and conclusion?

    Purchase Report for $ 4250 (Single User License) at

    The post Cancer Biomarkers appeared first on Journalist Book.

  • Via iCrowdNewswire
    View Related News >